Published in Hospital Business Week, February 25th, 2007
This trend article about Erasmus University, Netherlands, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Scientists discuss in "Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function" new findings in allergies. "Airway DCs play a crucial role in the pathogenesis of allergic asthma, and interfering with their function could constitute a novel form of therapy. The sphingosine 1-phosphate receptor agonist FTY720 is an oral immunosuppressant that retains lymphocytes in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.